5.38

5.38 (-0.00%)

As of Jan 14, 2022

Acumen Pharmaceuticals, Inc. [ABOS]

Source: 

Company Overview

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer’s disease, or AD. Alzheimer’s disease is a progressive neurodegenerative disease of the brain that leads to loss of memory and cognitive functions and ultimately results in death.

CountryUS
Headquarterscharlottesvillevirginia
Phone Number(925) 368-8508
Industry
CEODaniel O’Connell
Websiteacumenpharm.com